![Rolf Einar Engstad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rolf Einar Engstad is currently the Director at Biotec BetaGlucans AS.
Previously, he worked as the Chief Scientific Officer at ArcticZymes Technologies ASA. He received his graduate and doctorate degrees from the University of Tromso.
| Companies | Position | Start |
|---|---|---|
Biotec BetaGlucans AS
 Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
ArcticZymes Technologies ASA
 ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
University of Tromso
 University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
